Literature DB >> 27865387

MicroRNA expression signatures in lungs of mice infected with Mycobacterium tuberculosis.

Thiago Malardo1, Luiz Gustavo Gardinassi2, Bernardo Pereira Moreira3, Éverton Padilha2, Júlio César Cetrulo Lorenzi4, Luana Silva Soares2, Ana Flávia Gembre2, Isabela Cardoso Fontoura2, Luciana Previato de Almeida2, Isabel Kinney Ferreira de Miranda Santos2, Célio Lopes Silva2, Arlete Aparecida Martins Coelho-Castelo5.   

Abstract

Tuberculosis (TB) is a major public health concern worldwide; however the factors that account for resistance or susceptibility to disease are not completely understood. Although some studies suggest that the differential expression of miRNAs in peripheral blood of TB patients could be useful as biomarkers of active disease, their involvement during the inflammatory process in lungs of infected individuals is unknown. Here, we evaluated the global expression of miRNAs in the lungs of mice experimentally infected with Mycobacterium tuberculosis on 30 and 60 days post-infection. We observed that several miRNAs were differentially expressed compared to uninfected mice. Furthermore, we verified that the expression of miR-135b, miR-21, miR-155, miR-146a, and miR-146b was significantly altered in distinct leukocyte subsets isolated from lungs of infected mice, while genes potentially targeted by those miRNAs were associated with a diversity of immune related molecular pathways. Importantly, we validated the inhibition of Pellino 1 expression by miR-135b in vitro. Overall, this study contributes to the understanding of the dynamics of miRNA expression in lungs during experimental TB and adds further perspectives into the role of miRNAs on the regulation of immune processes such as leukocyte activation.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  MicroRNA; Microarray; Mycobacterium tuberculosis; Pellino 1; miR-135b

Mesh:

Substances:

Year:  2016        PMID: 27865387     DOI: 10.1016/j.tube.2016.09.003

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  6 in total

Review 1.  Unraveling the Role of MicroRNAs in Mycobacterium tuberculosis Infection and Disease: Advances and Pitfalls.

Authors:  Cinthya Ruiz-Tagle; Rodrigo Naves; María Elvira Balcells
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

2.  MiR-25 blunts autophagy and promotes the survival of Mycobacterium tuberculosis by regulating NPC1.

Authors:  Wenqi Dong; Gaoyan Wang; Jiajia Feng; Pei Li; Rui Wang; Hao Lu; Wenjia Lu; Chenchen Wang; Xiangru Wang; Huanchun Chen; Yaozu Xiang; Chen Tan
Journal:  iScience       Date:  2022-04-22

3.  Up-regulation of circRNA-0003528 promotes mycobacterium tuberculosis associated macrophage polarization via down-regulating miR-224-5p, miR-324-5p and miR-488-5p and up-regulating CTLA4.

Authors:  Zikun Huang; Fangyi Yao; Jun Liu; Jianqing Xu; Yang Guo; Rigu Su; Qing Luo; Junming Li
Journal:  Aging (Albany NY)       Date:  2020-12-09       Impact factor: 5.682

4.  Can miRNA Indicate Risk of Illness after Continuous Exposure to M. tuberculosis?

Authors:  Cleonardo Augusto Silva; Arthur Ribeiro-Dos-Santos; Wanderson Gonçalves Gonçalves; Pablo Pinto; Rafael Pompeu Pantoja; Tatiana Vinasco-Sandoval; André Maurício Ribeiro-Dos-Santos; Mara Helena Hutz; Amanda Ferreira Vidal; Gilderlanio Santana Araújo; Ândrea Ribeiro-Dos-Santos; Sidney Santos
Journal:  Int J Mol Sci       Date:  2021-04-01       Impact factor: 5.923

Review 5.  The Common miRNAs between Tuberculosis and Non-Small Cell Lung Cancer: A Critical Review.

Authors:  Mojgan Sheikhpour; Hanie Abolfathi; Morteza Karimipoor; Abolfazl Movafagh; Mahbubeh Shahsavani
Journal:  Tanaffos       Date:  2021-03

6.  Identifying differentially expressed long non-coding RNAs in PBMCs in response to the infection of multidrug-resistant tuberculosis.

Authors:  Hong Yan; Rufeng Xu; Xiangrong Zhang; Qian Wang; Jing Pang; Xia Zhang; Xiaoai Chang; Yaqin Zhang
Journal:  Infect Drug Resist       Date:  2018-07-13       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.